Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
Clinical trial NCT01899092 · COMPLETED
Trial details
- NCT number
- NCT01899092
- Sponsor
- Tacere Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.